Research Article
Olaparib Outcomes in Patients with BRCA 1-2 Mutated, Platinum-Sensitive, Recurrent Ovarian Cancer in Croatia: A Retrospective Noninterventional Study
| | Any grade | Grades 3-4 | n (%) | (95% CI) | n (%) | (95% CI) |
| Any toxicity | 61 (88) | (78–95) | 12 (17) | (9–28) | Hematologic toxicity | 35 (51) | (38–63) | 12 (17) | (9–28) | Anemia | 29 (42) | (30–55) | 9 (13) | (6–23) | Neutropenia | 14 (20) | (12–32) | 3 (4) | (1–12) | Elevation of creatinine | 10 (14) | (7–25) | 1 (1) | (0–8) | Thrombocytopenia | 4 (6) | (2–14) | 3 (4) | (1–12) | Nonhematologic toxicity | 54 (78) | (67–87) | 0 (0) | (0–5) | Fatigue | 48 (70) | (57–80) | 0 (0) | (0–5) | Nausea | 31 (45) | (33–57) | 0 (0) | (0–5) | Constipation | 4 (6) | (2–14) | 0 (0) | (0–5) | Vomit | 3 (4) | (1–12) | 0 (0) | (0–5) | Diarrhea | 3 (4) | (1–12) | 0 (0) | (0–5) | Artalgia | 3 (4) | (1–12) | 0 (0) | (0–5) | Abdominal pain | 2 (3) | (0–10) | 0 (0) | (0–5) |
|
|